Altered kynurenine metabolism correlates with infarct volume in stroke

European Journal of Neuroscience

Volumn 26, Issue 8, 2007, Pages 2211-2221

  Darlington, L G ^a   Mackay, G M ^b   Forrest, C M ^b   Stoy, N ^a   George, C ^a   Stone, T W ^b  

^a EPSOM GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Kynurenic acid; Kynurenines; Oxidative stress; S100B; Stroke; Tryptophan

Indexed keywords

3 HYDROXYANTHRANILIC ACID; ANTHRANILIC ACID; KYNURENINE; PROTEIN S100B; TRYPTOPHAN;

AGED; AMINO ACID METABOLISM; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; CELL ACTIVATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG INHIBITION; DRUG METABOLISM; ENCEPHALITIS; FEMALE; HUMAN; INTERVENTION STUDY; MALE; MICROGLIA; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STROKE; SURVIVAL; TRYPTOPHAN METABOLISM;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN INFARCTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; KYNURENINE; LIPID PEROXIDATION; MALE; MODELS, BIOLOGICAL; NEOPTERIN; NERVE GROWTH FACTORS; S100 PROTEINS; STATISTICS AS TOPIC; STROKE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRYPTOPHAN;

EID: 35448978696     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05838.x     Document Type: Article

References (102)

1. Abraha, H.D., Butterworth, R.J., Bath, P.M.W., Wassif, W.S., Garthwaite, J. Sherwood, R.A. (1997) Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann. Clin. Biochem., 34, 366 370.
2. Adami, C., Bianchi, R., Pula, G. Donato, R. (2004) S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta - Mol. Cell Res., 1742, 169 177.
3. Ahlemeyer, B., Beier, H., Semkova, I., Schaper, C. Krieglstein, J. (2000) S100beta protects cultured neurones against glutamate and staurosporine-induced damage and is involved in the anti-apoptotic action of the 5HT(1A)-receptor agonist, BAY X3702. Brain Res., 858, 121 128.
4. Amann, A., Widner, B., Rieder, J., Antretter, H., Hoffmann, G., Mayr, V., Strohmenger, H.U. Fuchs, D. (2001) Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest. Med. Inflammation, 10, 343 346.
5. Aurell, A., Rosengren, L.E., Karlsson, B., Olsson, J.-E., Zbornikova, V. Haglid, K.G. (1991) Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke, 22, 1254 1258.
6. Bacciottini, L., Pellegrini-Giampietro, D.E., Bongianno, F., Deluca, G., Beni, M., Politi, V. Moroni, F. (1987) Biochemical and behavioral-studies on indole-pyruvic acid - a keto-analogue of tryptophan. Pharmacol. Res. Commun., 19, 803 817.
7. Baran, H., Kepplinger, B., Herrera-Marschitz, M., Stolze, K., Lubec, G. Nohl, H. (2001) Increased kynurenic acid in the brain after neonatal asphyxia. Life Sci., 69, 1249 1256.
8. Baran, H. Schwarcz, R. (1990) Presence of 3-hydroxyanthranilic acid in rat-tissues and evidence for its production from anthranilic acid in the brain. J. Neurochem., 55, 738 744.
9. Baran, H., Staniek, K., Kepplinger, B., Stur, J., Draxler, M. Nohl, H. (2003) Kynurenines and the respiratory parameters on rat heart mitochondria. Life Sci., 72, 1103 1115.
10. Barger, S.W., Van Eldik, L.J. Mattson, M.P. (1995) S100beta protects hippocampal neurones from damage induced by glucose deprivation. Brain Res., 677, 167 170.
11. Barone, F.C. Feuerstein, G.Z. (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab., 19, 819 834.
12. Barone, F.C. Kilgore, K.S. (2006) Role of inflammation and cellular stress in brain injury and central nervous system diseases. Clin. Neurosci. Res., 6, 329 356.
13. Bauer, T.M., Jiga, L.P., Chuang, J.J., Randazzo, M., Opelz, G. Terness, P. (2005) Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transplant Internat., 18, 95 100.
14. Bayir, H., Kagan, V.E., Clark, R.S.B., Janesko-Feldman, K., Rafikov, R., Huang, Z., Zhang, X., Vagni, V., Billiar, T.R. Kochanek, P.M. (2007) Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J. Neurochem., 101, 168 181.
15. Behan, W.M.H. Stone, T.W. (2000) Role of kynurenines in the neurotoxic actions of kainic acid. Br. J. Pharmacol., 129, 1764 1770.
16. Block, M.L. Hong, J.S. (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol., 76, 77 98.
17. Block, M.L., Zecca, L. Hong, J.S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 8, 57 69.
18. Buttner, T., Weyers, S., Postert, T., Sprengelmeyer, R. Kuhn, W. (1997) S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke, 28, 1961 1965.
19. Cannazza, G., Baraldi, M., Braghiroli, D., Tait, A. Parenti, C. (2003) High performance liquid chromatography method for the quantification of anthranilic and 3-hydroxyanthranilic acid in rat brain dialysate. J. Pharm. Biomed. Anal., 32, 287 293.
20. Christensen, H., Boysen, G. Hjorth Johannesen, H. (2004) Serum-cortisol reflects severity and mortality in acute stroke. J. Neurol. Sci., 217, 175 180.
21. Clark, C.J., Mackay, G.M., Smythe, G.A., Bustamante, S., Stone, T.W. Phillips, R.S. (2005) Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infection Immunity, 73, 5249 5251.
22. Cozzi, A., Carpenedo, R. Moroni, F. (1999) Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2YL]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J. Cereb. Blood Flow Metab., 19, 771 777.
23. Diemer, N.H., Valente, E., Bruhn, T., Berg, M., Jorgensen, M.B. Johansen, F.F. (1993) Glutamate-receptor transmission and ischemic nerve-cell damage - evidence for involvement of excitotoxic mechanisms. Prog. Brain Res., 96, 105 123.
24. Dirnagl, U., Iadecola, C. Moskowitz, M.A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci., 22, 391 397.
25. Donato, R. (1991) Perspectives in S100 protein biology. Cell Calcium, 12, 713 726.
26. Dykens, J.A., Sullivan, S.G. Stern, A. (1987) Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. Biochem. Pharmacol., 36, 211 217.
27. Espey, M.G., Chernyshev, O.N., Reinhard, J.F., Namboodiri, M.A.A. Colton, C.A. (1997) Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport, 8, 431 434.
28. Espey, M.G., Moffett, J.R. Namboodiri, M.A.A. (1995) Temporal and spatial changes of quinolinic acid immunoreactivity in the immune-system of lipopolysaccharide-stimulated mice. J. Leukocyte Biol., 57, 199 206.
29. Esposito, G., De Filippis, D., Cirillo, C., Sarnelli, G., Cuomo, R. Iuvone, T. (2006) The astroglial-derived S100 beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. Life Sci., 78, 2707 2715.
30. Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M.C. Puccetti, P. (2002) T cell apoptosis by tryptophan catabolism. Cell Death Diff., 9, 1069 1077.
31. Forrest, C.M., Mackay, G.M., Oxford, L., Stoy, N., Stone, T.W. Darlington, L.G. (2006) Kynurenine pathway metabolism in patients with osteoporosis after two years of drug treatment. Clin. Exp. Pharmacol. Physiol., 33, 1078 1087.
32. Forrest, C.M., Mackay, G.M., Stoy, N., Egerton, M., Christofides, J., Stone, T.W. Darlington, L.G. (2004) Tryptophan loading induces oxidative stress. Free Rad. Res., 38, 1167 1171.
33. Fuchs, D., Moeller, A.-A., Reibnegger, G., Stoeckle, E., Werner, E.-R. Wachter, H. (1990) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J. Acquired Immune Def. Synd., 3, 873 876.
34. Gaubert, S., Bouchaut, M., Brumas, V. Berthon, G. (2000) Copper-ligand interactions and physiological free radical processes. Part 3. Influence of histidine, salicylic acid and anthranilic acid on copper-driven fenton chemistry in vitro. Free Rad. Res., 32, 451 461.
35. Gazzolo, D., Bruschettini, M., Lituania, M., Serra, G., Bonacci, W. Michetti, F. (2001) Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin. Chem., 47, 1836 1838.
36. Gazzolo, D., Masetti, P., Meli, M., Grutzfeld, D. Michetti, F. (2002) Elevated S100B protein as an early indicator of intracranial haemorrhage in infants subjected to extracorporeal membrane oxygenation. Acta Paediatr., 91, 218 221.
37. Gazzolo, D., Vinesi, P., Bartocci, M., Geloso, M.C., Bonacci, W., Serra, G., Haglid, K.G. Michetti, F. (1999) Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants: correlation with cerebral Doppler velocimetry. J. Neurol. Sci., 170, 32 35.
38. Gehrmann, J., Banati, R.B., Wiessnert, C., Hossmann, K.A. Kreutzberh, G.W. (1995) Reactive microglia in cerebral ischemia - an early mediator of tissue damage. Neuropath. Appl. Neurobiol., 21, 277 289.
39. Giles, G.I., Collins, C.A., Stone, T.W. Jacob, C. (2003) Electrochemical and in vitro evaluation of the redox properties of kynurenine species. Biochem. Biophys. Res. Commun., 300, 719 724.
40. Goldstein, L.E., Leopold, M.C., Huang, X.D., Atwood, C.S., Saunders, A.J., Hartshorn, M., Lim, J.T., Faget, K.Y., Muffat, J.A., Scarpa, R.C., Chylack, L.T., Bowden, E.F., Tanzi, R.E. Bush, A.I. (2000) 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry, 39, 7266 7275.
41. Halova-Lajoie, B., Brumas, W., Fiallo, M.M.L. Berthon, G. (2006) Copper(II) interactions with non-steroidal anti-inflammatory agents. III-3-Methoxyanthranilic acid as a potential (OH)-O-center dot-inactivating ligand: a quantitative investigation of its copper handling role in vivo. J. Inorg. Biochem., 100, 362 373.
42. Harris, C.A., Miranda, A.F., Tanguay, J.J., Boegman, R.J., Beninger, R.J. Jhamandas, K. (1998) Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Br. J. Pharmacol., 124, 391 399.
43. Herrmann. M., Vos. P., Wunderlich. M.T., de Bruijn. C.H.M.M. Lamers, K.J.B. (2000) Release of glial tissue-specific proteins after acute stroke. A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke, 31, 2670 2677.
44. Herve, C., Beyne, P., Jamault, H. Delacoux, E. (1996) Determination of tryptophan and its kynurenine pathway metabolites in human serum by HPLC with simultaneous UV and fluorimetric detection. J. Chromatogr. B Biomed. Appl., 675, 157 161.
45. Heyes, M.P. (1993) Quinolinic acid and inflammation. Ann. N.Y. Acad. Sci., 679, 211 216.
46. Heyes, M.P., Achim, C.L., Wiley, C.A., Major, E.O., Saito, K. Markey, S.P. (1996) Human microglia convert 1-tryptophan into the neurotoxin quinolinic acid. Biochem. J., 320, 595 597.
47. Heyes, M.P., Saito, K., Crowley, J.S., Davis, L.E., Der Demitrack, M.A.M., Dilling, L.A., Elia, J., Kruesi, M.J.P., Lackner, A., Larsen, S.A., Lee, K., Leonard, H.L., Markey, S.P., Martin, A., Milstein, S., Mouradian, M.M., Pranzatelli, M.R., Quearry, B.J., Salazar, A., Smith, M., Strauss, S.E., Sunderland, T., Swedo, S.W. Tourtellotte, W.W. (1992a) Quinolinic acid and kynurenine pathway metabolism in inflammatory and noninflammatory neurological disease. Brain, 115, 1249 1273.
48. Heyes, M.P., Saito, K. Markey, S.P. (1992b) Human macrophages convert 1-tryptophan into the neurotoxin quinolinic acid. Biochem. J., 283, 633 635.
49. Hoffmann, G. Schobersberger, W. (2004) Neopterin: a mediator of the cellular immune system. Pteridines, 15, 107 112.
50. Hoyte, L., Barber, P.A., Buchan, A.M. Hill, M.D. (2004) The rise and fall of NMDA antagonists for ischemic stroke. Curr. Mol. Med., 4, 131 136.
51. Huang, J., Uphadyay, U.M. Tamargo, R.J. (2006) Inflammation in stroke and focal cerebral ischemia. Surg. Neurol., 66, 232 245.
52. Ikonomidou, C. Turski, L. (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol., 1, 383 386.
53. Kepplinger, B., Baran, H., Kainz, A., Ferraz-Leite, H., Newcombe, J. Kalina, P. (2005) Age-related increase of kynurenic acid in human cerebrospinal fluid-IgG and beta(2)-microglobulin changes. Neurosignals, 14, 126 135.
54. Kim, S.H., Smith, C.J. Van Eldik, L.J. (2004) Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol. Aging, 25, 431 439.
55. Koppal, T., Lam, A.G.M., Guo, L. Van Eldik, L.J. (2001) S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia. Neurochem. Int., 39, 401 407.
56. Lastres-Becker, I., Cartmell, T. Molina-Holgado, F. (2006) Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1 beta and TNF-alpha. J. Neuroimmunol., 173, 108 116.
57. Leipnitz, G., Schumacher, C., Dalcin, K.B., Scussiato, K., Solano, A., Funchal, C., Dutra-Filho, C.S., Wyse, A.T.S., Wannmacher, C.M.D., Latini, A. Wajner, M. (2006) In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochem. Int., 50, 83 94.
58. Leira, R., Rodriguez-Yanez, M., Castellanos, M., Blanco, M., Nombela, F., Sobrino, T., Lizasoain, I., Davalos, A. Castillo, J. (2006) Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. J. Int. Med., 260, 343 349.
59. Liu, L., Li, Y.K., Van Eldik, L.J., Griffin, W.S.T. Barger, S.W. (2005) S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J. Neurochem., 92, 546 553.
60. Lopez, A.S., Alegre, E., LeMaoult, J., Carosella, E. Gonzalez, A. (2006) Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. Mol. Immunol., 43, 2151 2160.
61. Luchowski, P. Urbanska, E.M. (2007) SNAP and SIN-1 increase brain production of kynurenic acid. Eur. J. Pharmacol., 563, 130 133.
62. Mackay, G.M., Forrest, C.M., Stoy, N., Christofides, J., Egerton, M., Stone, T.W. Darlington, L.G. (2006) Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur. J. Neurol., 13, 30 42.
63. Marquardt, L., Ruf, A., Mansmann, U., Winter, R., Buggle, F., Kallenberg, K. Grau, A.J. (2005) Inflammatory response after acute stroke. J. Neurol. Sci., 236, 65 71.
64. McCulloch, J. Dewar, D. (2001) Commentary - a radical approach to stroke therapy. Proc. Natl Acad. Sci. USA, 98, 10989 10991.
65. Miche, H., Brumas, V. Berthon, G. (1997) Copper(II) interactions with nonsteroidal antiinflammatory agents. 2. Anthranilic acid as a potential (OH)-O-center dot-inactivating ligand. J. Inorg. Biochem., 68, 27 38.
66. Missler, U., Wiesmann, M., Friedrich, C. Kaps, M. (1997) S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke, 28, 1956 1960.
67. Nakamura, T., Keep, R.F., Hua, Y., Hoff, J.T. Xi, G.H. (2005) Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res., 1039, 30 36.
68. Perkins, M.N. Stone, T.W. (1982) An iontophoretic investigation of the action of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res., 247, 184 187.
69. Pertovaara, M., Raitala, A., Lehtimaki, T., Karhunen, P.J., Oja, S.S., Jylha, M., Hervonen, A. Hurme, M. (2006) Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech. Ageing Dev., 127, 497 499.
70. Petrova, T.V., Hu, J.R. Van Eldik, L.J. (2000) Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures. Brain Res., 853, 74 80.
71. Platten, M., Ho, P.P., Youssef, S., Fontoura, P., Garren, H., Hur, E.M., Gupta, R., Lee, L.Y., Kidd, B.A., Robinson, W.H., Sobel, R.A., Selley, M.L. Steinman, L. (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science, 310, 850 855.
72. Politi, V., Deluca, G., Gallai, V., Puca, O. Comin, M. (1999) Clinical experiences with the use of indole-3-pyruvic acid. Adv. Exp. Med. Biol., 467, 227 232.
73. Prass, K. Dirnagl, U. (1998) Glutamate antagonists in therapy of stroke. Restor. Neurol. Neurosci., 13, 3 10.
74. Price, C.J.S., Wang, D.C., Menon, D.K., Guadagno, J.V., Cleij, M., Fryer, T., Aigbirhio, F., Baron, J.C. Warburton, E.A. (2006) Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke, 37, 1749 1753.
75. Pulsinelli, W., Sarokin, A. Buchan, A. (1993) Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia. Progr. Brain Res., 96, 125 135.
76. Saito, K., Markey, S.P. Heyes, M.P. (1992) Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience, 51, 25 39.
77. Schmidt, S. (1998) S100B: pathogenetic and pathophysiological implications in neurology. Nervenzart, 69, 639 646.
78. Schroecksnadel, K., Murr, C., Winkler, C., Wirleitner, B., Fruith, L.C. Fuchs, D. (2004) Neopterin to monitor clinical pathologies involving interferon-gamma production. Pteridines, 15, 75 90.
79. Schwarcz, R., Whetsell, W.O. Mangano, R.M. (1983) Quinolinic acid - an endogenous metabolite that produces axon-sparing lesions in rat-brain. Science, 219, 316 318.
80. Shibata, K. (1988) Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by HPLC. J. Chromatogr. B Biomed. Appl., 430, 376 380.
81. Skinner, R., Georgiou, R., Thornton, P. Rothwell, N. (2006) Psychoneuroimmunology of stroke. Neurologic Clinics, 24, 561 570.
82. Sperner-Unterweger, B., Miller, C., Holzner, B., Laich, A., Widner, B., Fleischhacker, W.W. Fuchs, D. (2002) Immunologic alterations in schizophrenia: neopterin, 1-kynurenine, tryptophan and T-cell subsets in the acute stage of illness. Pteridines, 13, 9 14.
83. Stone, T.W. (1993) The neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev., 45, 309 379.
84. Stone, T.W. (2001) Kynurenines in the CNS - from obscurity to therapeutic importance. Progr. Neurobiol., 64, 185 218.
85. Stone, T.W. (2007) Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Eur. J. Neurosci., 25, 2656 2665.
86. Stone, T.W. Darlington, L.G. (2002) Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug Discovery, 1, 609 620.
87. Stone, T.W. Perkins, M.N. (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol., 72, 411 412.
88. Tanaka, Y., Koizumi, C., Marumo, T., Omura, T. Yoshida, S. (2007) Serum S100B indicates brain edema formation and predicts long-term neurological outcomes in rat transient middle cerebral artery occlusion model. Brain Res., 1137, 140 145.
89. Terness, P., Bauer, T.M., Rose, L., Dufter, C., Watzlik, A., Simon, H. Opelz, G. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med., 196, 447 457.
90. Thomas, S.R. Stocker, R. (1999) Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Report, 4, 199 220.
91. Thomas, S.R., Witting, P.K. Stocker, R. (1996) 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for alpha-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation. J. Biol. Chem., 271, 32714 32721.
92. Vexler, Z.S., Tang, X.N. Yenari, M.A. (2006) Inflammation in adult and neonatal stroke. Clin. Neurosci. Res., 6, 293 313.
93. Weber, W.P., Feder-Mengus, C., Chiarugi, A., Rosenthal, R., Reschner, A., Schumacher, R., Zajaz, P., Misteli, H., Frey, D.M., Oertli, D., Heberer, M. Spagnoli, G.C. (2006) Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8(+) T cells induced by TCR triggering or homeostatic cytokines. Eur. J. Immunol., 36, 296 304.
94. Weiss, G., Diez-Ruiz, A., Murr, C., Theurl, I. Fuchs, D. (2002) Tryptophan metabolites as scavengers of reactive oxygen and chlorine species. Pteridines, 13, 140 144.
95. Werner, E.R., Bitterlich, G., Fuchs, D., Hausen, A., Reibnegger, G. Szabo, G. (1987) Human macrophages degrade tryptophan upon induction by interferon-γ. Life Sci., 41, 273 280.
96. Werner, E.R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G. Wachter, H. (1989) Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem. J., 262, 861 866.
97. White, B.C., Sullivan, J.M., De Gracia, D.J., O'Neill, B.J., Neumar, R.W., Grossman, L.I., Rafols, J.A. Krause, G.S. (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci., 179, 1 33.
98. Widner, B., Ledochowski, M. Fuchs, D. (2000) Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. Curr. Drug Metabol., 1, 193 204.
99. Wirleitner, B., Neurauter, G., Schrocksnadel, K., Frick, B. Fuchs, D. (2003a) Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem., 10, 1581 1591.
100. Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Erglis, A., Trusinskis, K. Fuchs, D. (2003b) Immune activation and degradation of tryptophan in coronary heart disease. Eur. J. Clin. Invest., 33, 550 554.
101. Wunderlich, M.T., Wallesch, C.-W. Goertler, M. (2004) Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J. Neurol. Sci., 227, 49 53.
102. Zhang, C.H., Xu, X.B., Potter, B.J., Wang, W., Kuo, L., Michael, L., Bagby, G.J. Chilian, W.M. (2006) TNF-α contributes to endothelial dysfunction in ischemia/reperfusion injury. Arteriosclerosis Thromb. Vasc. Biol., 26, 475 480.